PMID: 9421702Jan 9, 1998Paper

Antimicrobial resistance in staphylococci. Epidemiology, molecular mechanisms, and clinical relevance

Infectious Disease Clinics of North America
M C MarananR S Daum

Abstract

Staphylococcal infections continue to pose important clinical problems in children and adults. Antibiotic resistance among the staphylococci has rendered therapy of these infections a therapeutic challenge. Despite early, uniform susceptibility to penicillin, staphylococci acquired a gene elaborating beta-lactamase that rendered penicillin inactive and that is borne by nearly all clinical isolates. "Penicillinase-resistant beta-lactams," such as methicillin, were introduced in the early 1960s, but resistance to them has become an increasing concern. The mechanism of the so-called "methicillin resistance" is complex. Moreover, once confined to the ecology of hospitals and other institutions, a recent increase in community-acquired methicillin-resistant S. aureus infections has been observed. Glycopeptides, until now the only uniformly reliable therapeutic modality, have been increasingly used for therapy of staphylococcal infections. The recent recognition of clinical isolates with reduced susceptibility to glycopeptides is of concern.

References

Sep 1, 1977·Medicine·D M Musher, S O McKenzie
Apr 1, 1978·Journal of Clinical Pathology·W A GillespieA L Hilton
Oct 1, 1977·Southern Medical Journal·R C MoelleringB A Mercier
May 1, 1975·Journal of General Microbiology·E H Asheshov
May 1, 1976·Annals of Internal Medicine·P B Iannini, K Crossley
Dec 1, 1992·The Journal of Antimicrobial Chemotherapy·M D O'Hare, P E Reynolds
Mar 1, 1992·Antimicrobial Agents and Chemotherapy·J E GustafsonB J Wilkinson
Jan 1, 1992·Antimicrobial Agents and Chemotherapy·C RyffelB Berger-Bächi
Oct 1, 1992·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·A L PanlilioW J Martone
Oct 1, 1992·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·R C HershowN L Smith
Feb 1, 1992·Antimicrobial Agents and Chemotherapy·D J ZygmuntD S Kernodle
Sep 1, 1991·Antimicrobial Agents and Chemotherapy·T L BannermanW E Kloos
Jan 1, 1991·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·H F Chambers
May 1, 1991·The Journal of Infectious Diseases·G W KaatzC A Ruble
Apr 1, 1991·The Journal of Antimicrobial Chemotherapy·D S ReevesJ M Andrews
Sep 16, 1991·The American Journal of Medicine·D R SchabergR P Gaynes
Nov 1, 1991·Annals of Internal Medicine·A W Karchmer
Jan 1, 1991·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·J M Boyce

❮ Previous
Next ❯

Citations

Feb 13, 1999·Comprehensive Therapy·R L Lark, C Chenoweth
Nov 15, 2011·Seminars in Immunopathology·Kevin M Rigby, Frank R DeLeo
Aug 29, 2006·Current Infectious Disease Reports·Warren S Joseph
Apr 1, 2000·Diagnostic Microbiology and Infectious Disease·A K JafriG L Woods
Aug 22, 2001·International Journal of Antimicrobial Agents·O TüngerH Aksoy
Mar 6, 1999·Current Opinion in Microbiology·A MorrisD E Low
Aug 31, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·T S NaimiK E Smith
May 17, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dennis L StevensBarry Hafkin
Dec 18, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Benjamin A LipskyUNKNOWN Linezolid Diabetic Foot Infections Study Group
Jan 1, 2005·Surgical Infections·David J Weber, William A Rutala
Apr 30, 2008·Antimicrobial Agents and Chemotherapy·Kevin M KrauseBret M Benton
Jan 20, 2000·Antimicrobial Agents and Chemotherapy·S Boyle-VavraR S Daum
Apr 17, 2001·Antimicrobial Agents and Chemotherapy·S ChamberlandM N Dudley
Oct 25, 2003·Antimicrobial Agents and Chemotherapy·John L PaceKoné Kaniga
Feb 26, 2004·Antimicrobial Agents and Chemotherapy·Anton LeightonEllen Kelly
Sep 25, 2012·Applied and Environmental Microbiology·Sandeep KaurSanjay Chhibber
Feb 27, 2001·Postgraduate Medical Journal·W J Steinbach, A K Shetty
Aug 2, 2002·Postgraduate Medical Journal·A S HaddadinP A Lipsett
Dec 23, 2006·Environmental Health Perspectives·Angelina GandaraShawn G Gibbs
Jul 31, 2007·Future Microbiology·Annalisa PantostiMonica Monaco
Oct 24, 2007·Pharmacotherapy·Dennis G MakiSteven C Ebert
Apr 2, 2004·The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons·Thomas ZgonisJuan C Garbalosa
Jun 10, 2004·Revista portuguesa de pneumologia·Isabel Ribeiro, Rui Castanheira
Feb 1, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·G C Schito
Feb 23, 2000·Mayo Clinic Proceedings·A Virk, J M Steckelberg
Apr 28, 2004·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·William A Rutala, David J Weber
Feb 8, 2005·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Lou Ann Bruno-MurthaDeborah Zucker
Sep 29, 2006·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·R RozenbaumA M S Figueiredo
Mar 30, 2000·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·A J KallenM R Wallace
Jun 28, 2003·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Julie KennerDuane Hospenthal
Jun 28, 2003·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·John B SealRobert S Daum
Jan 12, 2000·Pediatric Clinics of North America·J Bennett, J W St Geme
Aug 6, 2010·Foot & Ankle Specialist·Christy L ScimecaDavid G Armstrong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.